Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences N (JFNNX)

69.85 -0.44 (-0.63%)
As of 8:05 AM EDT. Market Open.

Top 10 Holdings (37.34% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 6.63%
UNH
UnitedHealth Group Incorporated 5.96%
NOVO-B.CO
Novo Nordisk A/S 4.81%
MRK
Merck & Co., Inc. 3.56%
AZN.L
AstraZeneca PLC 3.56%
ABBV
AbbVie Inc. 3.21%
ABT
Abbott Laboratories 2.49%
SAN.PA
Sanofi 2.46%
VRTX
Vertex Pharmaceuticals Incorporated 2.37%
BSX
Boston Scientific Corporation 2.29%

Sector Weightings

SectorJFNNX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.63%
Stocks 98.20%
Bonds 0.00%
Others 0.88%
Preferred 0.23%
Convertible 0.05%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average JFNNX Category Average
Price/Earnings 0.03 24.55
Price/Book 0.19 5.28
Price/Sales 0.39 2.06
Price/Cashflow 0.05 17.54
Median Market Cap 57,038.85 34,862.81
3 Year Earnings Growth 2.84 32.48

Bond Holdings

Performance & Risk

YTD Return 1.25%
5y Average Return 11.55%
Rank in Category (ytd) 28
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.73
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Janus Henderson
Net Assets 5.37B
YTD Return 8.60%
Yield 0.20%
Morningstar Rating
Inception Date Jul 06, 2009

Fund Summary

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Related Tickers